About Syncona
Syncona is a company based in London (United Kingdom) founded in 2012. Syncona has completed 4 acquisitions, including Applied Genetics Technologies Corporation, Freeline and Omass. Syncona offers products and services including Investment Management and Portfolio Development.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Syncona Ltd Gbp
-
Annual Revenue
$125.56 M (USD)65.61as on Mar 31, 2025
-
Net Profit
-$185.34 M (USD)-3879.3as on Mar 31, 2025
-
EBITDA
-$184.41 M (USD)-3508.38as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Syncona
Syncona is a publicly listed company on the LSE with ticker symbol SYNC in UK, operating in the Miscellaneous sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Syncona
Syncona offers a comprehensive portfolio of products and services, including Investment Management and Portfolio Development.
Investments are managed in life science companies to support development of therapeutics
Portfolios are developed by building and overseeing biotechnology firms across clinical stages
People of Syncona
Unlock access to complete
Unlock access to complete
Funding Insights of Syncona
Detailed funding history for Syncona
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Syncona
Syncona has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Applied Genetics Technologies Corporation, Freeline and Omass.
Investment portfolio details for Syncona
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Native mass spectrometry services for protein characterization are provided.
|
Locked | Locked | 2016 | Locked | |
|
Gene therapy platform is developed for chronic disease treatments.
|
Locked | Locked | 2015 | Locked | |
|
Clinical-stage biotech company advancing gene therapies for rare and neurological diseases.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Syncona
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Syncona
Detailed financials for Syncona
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Syncona Comparisons
Peer comparison for Syncona
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Syncona
Detailed competitors of Syncona
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Syncona
Complete news archive for Syncona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syncona
Syncona was founded in 2012.
Syncona is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of Syncona is $125.56M as on Mar 31, 2025.
Syncona was founded in 2012 and is headquartered in London, United Kingdom. Focus is placed on private equity investments within the healthcare sector, where portfolio companies are supported through funding and strategic guidance. Operations encompass identifying and nurturing early-stage biotechs and medtech firms, with a team of partners and directors overseeing activities from the UK base. Services include capital deployment and operational expertise for healthcare innovators.
Syncona offers Investment Management and Portfolio Development.
Yes, Syncona is publicly traded on LSE under the ticker symbol SYNC.
Syncona has made 4 acquisitions, including Applied Genetics Technologies Corporation, Freeline, and Omass.
The ticker symbol of Syncona is SYNC on LSE.